search
Back to results

Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial (ESP)

Primary Purpose

Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Morphine
Ultrasound-guided erector spinae plane block
Sponsored by
The Netherlands Cancer Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction focused on measuring Ultrasound-guided erector spinae plane block, paravertebral block

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients (18 years of age or older)
  • ASA I-III
  • Patients scheduled for elective unilateral mastectomy followed by direct reconstruction
  • Ability to give written and oral informed consent

Exclusion Criteria:

  • Patient refusal
  • Non-elective surgery
  • Any contraindication to paravertebral block (including bleeding diathesis, coagulopathy, severe pulmonary disease )
  • Allergy to amide-linked local anesthetics
  • Cardiac conductivity disorders (e:g: 2nd and 3rd AV-block)
  • Severe spinal malformations or history of extensive spine surgery - A history of spinal cord injury
  • Known psychiatric disorder
  • Chronic pain patients or patients already using opioids pre-operatively
  • Infection of the skin at the site of needle puncture area - Inability to give oral and written informed consent

Sites / Locations

  • NKI-AvLRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

paravertebral block

Ultrasound-guided erector spinae plane block

Arm Description

Outcomes

Primary Outcome Measures

Mean difference of highest numerical rating score (NRS - a linear 11 point scale for self-reported pain) during admission in the recovery room
Difference in the ratio of the means of cumulative opioid dose (administered during admission in the recovery room)

Secondary Outcome Measures

Success rate as defined by satisfactory spread of local anaesthetic agents on ultrasound
Ease of procedure (self-reported by anaesthetist on scale of 1-5)
Total opioid dose administered on day 0 and on day 1 (iv, subcutaneous or oral - converted to morphine equivalent dose (MEQ)
Highest pain score on day 0 and 1
Time to readiness for discharge from the recovery room
Complications of block (such as block failure, epidural hematoma, hemo- or pneumothorax and symptoms of toxicity of local anesthetics)
Patient satisfaction on a scale of 0 (extremely unsatisfied) tot 10 (extremely satisfied)

Full Information

First Posted
October 18, 2022
Last Updated
October 20, 2022
Sponsor
The Netherlands Cancer Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT05590559
Brief Title
Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial
Acronym
ESP
Official Title
Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial. A Single-centre Randomized Controlled Non-inferiority Trial With a Parallel Group Design
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
December 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Netherlands Cancer Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this study is to assess the non-inferiority of analgesic efficacy of ESP vs PVB for patients undergoing unilateral mastectomy followed by immediate reconstruction.
Detailed Description
n breast cancer treatment, surgery plays a central role in combination with chemotherapy, radiation and immunotherapy. Surgery may vary from conservative breast sparing interventions to large radical mastectomies with axillary lymph node dissection that require reconstructive (prosthetic) surgery. In many instances, reconstruction is not performed immediately, but immediate reconstruction is possible and offers many advantages to patients. The Antoni van Leeuwenhoek hospital performs a large proportion (77%) of mastectomies with immediate reconstruction in the Netherlands. The combination of mastectomy with immediate reconstruction in one operation offers an extra challenge with regards to pain control. Post-operative pain is often treated with opioids, which has systemic side effects (nausea and vomiting). Opioids also inhibit cell-mediated immunity, which is a principal defense against cancer. Regional anesthetic techniques are often performed to reduce opioid consumption and enhance postoperative recovery. The current standard for regional anesthesia for breast surgery is the paravertebral block (PVB). This technique has the potential for severe complications such as epidural hematoma, hemo- or pneumothorax. The erector spinae plane block (ESP) was first described in 2016 as a novel regional anesthetic technique for acute and chronic thoracic pain. The site of injection is distant from the pleura, major blood vessels, and spinal cord; hence, the ESP block has relatively few contraindications and has therefore been suggested as an alternative to PVB when contra-indications, such as a bleeding diathesis, are present.Multiple studies have shown a decrease in opioid consumption in patients undergoing mastectomy, when ESP was compared to placebo. ESP has also been shown to be non-inferior to PVB for pain relief in patients undergoing thoracotomy. To date, only two studies have compared ESP to PVB for breast surgery, with conflicting results. In this study, we would like to investigate whether ESP can be considered non-inferior to PVB with regards to pain relief and use of opioids.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction
Keywords
Ultrasound-guided erector spinae plane block, paravertebral block

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
paravertebral block
Arm Type
Active Comparator
Arm Title
Ultrasound-guided erector spinae plane block
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Morphine
Intervention Description
Opiates
Intervention Type
Other
Intervention Name(s)
Ultrasound-guided erector spinae plane block
Intervention Description
PVB
Primary Outcome Measure Information:
Title
Mean difference of highest numerical rating score (NRS - a linear 11 point scale for self-reported pain) during admission in the recovery room
Time Frame
1 day
Title
Difference in the ratio of the means of cumulative opioid dose (administered during admission in the recovery room)
Time Frame
1 day
Secondary Outcome Measure Information:
Title
Success rate as defined by satisfactory spread of local anaesthetic agents on ultrasound
Time Frame
1 month
Title
Ease of procedure (self-reported by anaesthetist on scale of 1-5)
Time Frame
1 month
Title
Total opioid dose administered on day 0 and on day 1 (iv, subcutaneous or oral - converted to morphine equivalent dose (MEQ)
Time Frame
1 day after dose administration
Title
Highest pain score on day 0 and 1
Time Frame
1 day
Title
Time to readiness for discharge from the recovery room
Time Frame
1 day
Title
Complications of block (such as block failure, epidural hematoma, hemo- or pneumothorax and symptoms of toxicity of local anesthetics)
Time Frame
1 day
Title
Patient satisfaction on a scale of 0 (extremely unsatisfied) tot 10 (extremely satisfied)
Time Frame
1 month

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
adult female patients
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients (18 years of age or older) ASA I-III Patients scheduled for elective unilateral mastectomy followed by direct reconstruction Ability to give written and oral informed consent Exclusion Criteria: Patient refusal Non-elective surgery Any contraindication to paravertebral block (including bleeding diathesis, coagulopathy, severe pulmonary disease ) Allergy to amide-linked local anesthetics Cardiac conductivity disorders (e:g: 2nd and 3rd AV-block) Severe spinal malformations or history of extensive spine surgery - A history of spinal cord injury Known psychiatric disorder Chronic pain patients or patients already using opioids pre-operatively Infection of the skin at the site of needle puncture area - Inability to give oral and written informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sandra Broens, PhD
Phone
+31(0)205122506
Email
s.broens@nki.nl
Facility Information:
Facility Name
NKI-AvL
City
Amsterdam
State/Province
Noord-Holland
ZIP/Postal Code
1066CX
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sandra Broens
Phone
+31205122506
Email
s.broens@nki.nl

12. IPD Sharing Statement

Learn more about this trial

Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial

We'll reach out to this number within 24 hrs